Effect of T injection and EGCG on T and DHT concentrations in serum and hairAnalysis using LC-MS ⁄ MS on serum and hair samples was performed to determine the difference in the T and DHT concentrations in each group. We found no difference in the T and DHT concentrations between the T-injected and T + EGCG groups (unpublished data).
ConclusionWe report the first in vivo experiment showing the influence of T injection and EGCG on hair follicles. Our results suggest that T injection in a B6CBAF1 ⁄ j mouse model induces hair loss by apoptosis of hair follicles rather than through the androgen metabolic pathway. Furthermore, it was shown that EGCG can prevent hair loss by reducing T-induced apoptosis of follicular epithelial cells and provoke hair re-growth after epilation.The best animal model of androgen-induced alopecia is the stump-tailed macaque, but because of its large size and high cost, researchers favour a more easily handled murine model (19). The B6CBAF1 ⁄ j mice used in this study were first introduced by Matias et al. (17) as a T-induced androgenic alopecia mice model. The B6CBAF1 ⁄ j mouse is not a perfect androgen-induced alopecia model in that androgen is needed to be given continuously, and once androgen supplementation ceases, the mouse regains its hair within 3 months. Because B6CBAF1 ⁄ j mice are convenient, costeffective and suitable with respect to the time course of results, B6CBAF1 ⁄ j mice were used in this study.Even though there was no difference in the expression of 17b-and 3b-HSD between the T-injected and T + EGCG groups, we cannot exclude the possibility of the effect of EGCG on androgen metabolism of hair follicles because EGCG application down-regulated T-induced AR expression of hair follicles. To resolve this question, further functional in vitro studies using hair follicle culture will be needed.From our study, we propose topical EGCG as a promising therapeutic tool in the management of androgen-related hair loss.
Acknowledgements
Conflict of interestThe authors declare no conflict of interests.
Supporting InformationAdditional Supporting Information may be found in the online version of this article: Figure S1. Immunohistochemical histology of the upper dorsal skin stained with androgen receptor (a-f). Table S1. Number of hair follicles counted by Folliscope Ò on day16 after epilation. Table S2. Comparison of the intensity of the apoptosis by TUNEL staining and immunohistochemical staining of androgen receptor of the treated groups.
Topical application of 10% EGCG (a), testosterone (T)'s vehicle injection (b), T injection (c), T injection + topical application of EGCG vehicle (ethanol)) (d), T injection + topical application of 10% cyproterone acetate (e), and T injection + topical application of EGCG (f) (·400).Appendix S1. Materials and methods. Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the ...